Katherine Payne (K Payne)

Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 28

Top Venues

Applied health economics and health policy

The patient

PharmacoEconomics

Journal of personalized medicine

University of Manchester

University of Manchester (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Manchester

United Kingdom

Professor of Health Economics :: Manchester Centre for Health Economics

Education History

University of Manchester

United Kingdom

PHD :: Pharmacy & Pharmaceutical Sciences

University of Bath

United Kingdom

BSC :: Pharmacy

Publications

Stuart James Wright, Ewan Gray, Gabriel Rogers, Anna Donten, Katherine Payne
A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening. Applied health economics and health policy 22 (4) (2024)
Stuart James Wright, Ewan Gray, Gabriel Rogers, Anna Donten, Katherine Payne
A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening. Applied health economics and health policy 22 (4) (2024)
Stuart James Wright, Ewan Gray, Gabriel Rogers, Anna Donten, Katherine Payne
A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening. Applied health economics and health policy 22 (4) (2024)
Stuart James Wright, Ewan Gray, Gabriel Rogers, Anna Donten, Katherine Payne
A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening. Applied health economics and health policy (2024)
Bruce Guthrie, Gabriel Rogers, Shona Livingstone, Daniel R Morales, Peter T Donnan, Sarah Davis, Ji-Hee Youn, Robert Hainsworth, Alexander James Thompson, Katherine Payne
The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis. Health and social care delivery research 12 (4) (2024)
Stuart James Wright, Ewan Gray, Gabriel Rogers, Anna Donten, Katherine Payne
A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening. Applied health economics and health policy 22 (4) (2024)
Alexander James Thompson, Ji-Hee Youn, Bruce Guthrie, Robert Hainsworth, Peter T Donnan, Gabriel Rogers, Daniel Morales, Katherine Payne
Quantifying the impact of taking medicines for primary prevention: a time-trade off study to elicit direct treatment disutility in the UK. BMJ open 13 (9) (2023)
Stuart James Wright, John McDermott, Dwaipayan Sen, Craig Smith, William Newman, Katherine Payne
Development of a point-of-care genetic test for effective treatment of ischaemic stroke: an early model-based cost-effectiveness analysis. Wellcome open research 8 (2023)
Sean P Gavan, Stuart James Wright, Fiona C Thistlethwaite, Katherine Payne
Capturing the Impact of Constraints on the Cost-Effectiveness of Cell and Gene Therapies: A Systematic Review. PharmacoEconomics (2023)
Lorna McWilliams, Dafydd Gareth Evans, Katherine Payne, Fiona Harrison, Anthony Howell, Sacha J Howell, David P French, null null
Implementing Risk-Stratified Breast Screening in England: An Agenda Setting Meeting. Cancers 14 (19) (2022)
Garima Dalal, Paul A Bromiley, Eleni P Kariki, Shawn Luetchens, Timothy F Cootes, Katherine Payne
Understanding current UK practice for the incidental identification of vertebral fragility fractures from CT scans: an expert elicitation study. Aging clinical and experimental research 34 (8) (2022)
Matthew J Jones, Ralph Kwame Akyea, Katherine Payne, Steve E Humphries, Hasidah Abdul-Hamid, Stephen Weng, Nadeem Qureshi
Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care. Journal of personalized medicine 12 (3) (2022)
Martin Eden, Robert Hainsworth, Louisa G Gordon, Tracy Epton, Paul C Lorigan, Lesley E Rhodes, Richard Marais, Adéle C Green, Katherine Payne
Cost-effectiveness of a policy-based intervention to reduce melanoma and other skin cancers associated with indoor tanning. The British journal of dermatology 187 (1) (2022)
Dina Janković, Katherine Payne, Mona Kanaan, Laura Bojke
Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect. International journal of technology assessment in health care 38 (1) (2022)
Caroline M Vass, Niall J Davison, Geert Vander Stichele, Katherine Payne
A Picture is Worth a Thousand Words: The Role of Survey Training Materials in Stated-Preference Studies. The patient 13 (2) (2021)
Caroline M Vass, Anne Barton, Katherine Payne
Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice Experiment. The patient (2021)
Garima Dalal, S J Wright, C M Vass, N J Davison, G Vander Stichele, C H Smith, Christopher Ernest Maitland Griffiths, Katherine Payne, null null
Patient preferences for stratified medicine in psoriasis: a discrete choice experiment. The British journal of dermatology 185 (5) (2021)
Cheryl Jones, Katherine Payne, Alexander Thompson, Suzanne M M Verstappen
Predicting presenteeism using measures of health status. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2021)
Cheryl Jones, Katherine Payne, Suzanne M M Verstappen
Using qualitative methods for a conceptual analysis of measures of health status and presenteeism prior to a mapping study. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 29 (11) (2020)
Stuart James Wright, William G Newman, Katherine Payne
Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review. PharmacoEconomics 37 (8) (2020)
Cheryl Jones, Suzanne M M Verstappen, Katherine Payne
A Systematic Review of Productivity in Economic Evaluations of Workplace Interventions: A Need for Reporting Criteria? Applied health economics and health policy 17 (5) (2020)
Sean P Gavan, Christine Y Lu, Katherine Payne
Assessing the Joint Value of Genomic-Based Diagnostic Tests and Gene Therapies. Journal of personalized medicine 9 (2) (2019)
Stuart James Wright, Caroline M Vass, Gene Sim, Michael Burton, Denzil G Fiebig, Katherine Payne
Accounting for Scale Heterogeneity in Healthcare-Related Discrete Choice Experiments when Comparing Stated Preferences: A Systematic Review. The patient 11 (5) (2019)
Caroline M Vass, Dan Rigby, Katherine Payne
"I Was Trying to Do the Maths": Exploring the Impact of Risk Communication in Discrete Choice Experiments. The patient 12 (1) (2019)
Caroline M Vass, Katherine Payne
Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet? PharmacoEconomics 35 (9) (2018)
Niall J Davison, Katherine Payne, Martin Eden, Marion McAllister, Stephen A Roberts, Stuart Ingram, Graeme C M Black, Georgina Hall
Exploring the feasibility of delivering standardized genomic care using ophthalmology as an example. Genetics in medicine : official journal of the American College of Medical Genetics 19 (9) (2017)
Cynthia P Iglesias, Alexander Thompson, Wolf H Rogowski, Katherine Payne
Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations. PharmacoEconomics 34 (11) (2017)
Katherine Payne, N Davison, A J Thompson, K O'Brien, I A Bruce
Use of a structured elicitation exercise to estimate the prevalence of OME in children with cleft palate. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 42 (4) (2016)

Katherine Payne.css-eqlu8i{font-size:small;padding-left:4px;} (K Payne)

Publication Activity (10 Years)

Top Topics

Top Venues

Katherine Payne (K Payne)